Tags: Chemical Compound, Chemical Substance.

Vicriviroc previously named SCH 417690 and SCH-D is a pyrimidine CCR5 entry inhibitor of HIV-1. It was developed by the pharmaceutical company Schering-Plough. Merck decided to not pursue regulatory approval for use in treatment-experienced patients because the drug did not meet primary efficacy endpoints in late stage trials. Clinical trials continue in patients previously untreated for HIV.

Vicriviroc_structure.svg
FDA UNII code
TL515DW4QS
IUPAC name
5-(4-[(3S)-4-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl-3-methylpiperazin-1-yl]-4-methylpiperidin-1-ylcarbonyl)-46-dimethylpyrimidine

Loading...

This page contains content from the copyrighted Wikipedia article "Vicriviroc"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.